Use of MRP8/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritis

The objective of this study was to determine the effectiveness of MRP8/14 as a predictor of disease flare in patients with juvenile idiopathic arthritis (JIA) following the withdrawal of methotrexate (MTX) in a routine clinical setting. All MRP8/14 tests performed at a single centre in a 27-month pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumner, Emma J., Almeida, Beverley, Palman, Jason, Bale, Peter, Heard, Clare, Holzinger, Dirk, Roth, Johannes, Foell, Dirk, Robinson, Emily, Ursu, Simona, Wallace, Chris, Gilmour, Kimberly, Wedderburn, Lucy R., Ralph, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474586/
https://www.ncbi.nlm.nih.gov/pubmed/35486225
http://dx.doi.org/10.1007/s10067-022-06165-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474586/
https://www.ncbi.nlm.nih.gov/pubmed/35486225
http://dx.doi.org/10.1007/s10067-022-06165-4

Ejemplares similares